scholarly journals Predicting Loss of Independence after High-risk Abdomen Surgery: Frailty vs NSQIP Risk Calculator

2021 ◽  
Vol 233 (5) ◽  
pp. S81-S82
Author(s):  
Abdimajid Mohamed ◽  
Timothy L. Fitzgerald
Keyword(s):  
2020 ◽  
Vol 21 (Supplement_1) ◽  
Author(s):  
D M Adamczak ◽  
M Bednarski ◽  
A Rogala ◽  
M Antoniak ◽  
T Kiebalo ◽  
...  

Abstract BACKGROUND Hypertrophic cardiomyopathy (HCM) is a heart disease characterized by hypertrophy of the left ventricular myocardium. The disease is the most common cause of sudden cardiac death (SCD) in young people and competitive athletes due to fatal ventricular arrhythmias, but in most patients, however, HCM has a benign course. Therefore, it is of the utmost importance to properly evaluate patients and identify those who would benefit from a cardioverter-defibrillator (ICD) implantation. The HCM SCD-Risk Calculator is a useful tool for estimating the 5-year risk of SCD. Parameters included in the model at evaluation are: age, maximum left ventricular wall thickness, left atrial dimension, maximum gradient in left ventricular outflow tract, family history of SCD, non-sustained ventricular tachycardia and unexplained syncope. Patients’ risk of SCD is classified as low (<4%), intermediate (4-<6%) or high (≥6%). Those in the high-risk group should have an ICD implantation. It can also be considered in the intermediate-risk group. However, the calculator still needs improvement and machine learning (ML) has the potential to fulfill this task. ML algorithm creates a model for solving a specific problem without explicit programming - instead it relies only on available data - by discovering patterns and relations. METHODS 252 HCM patients (aged 20-88 years, 49,6% were men) treated in our Department from 2005 to 2018, have been enrolled. The follow-up lasted 0-13 years (average: 3.8 years). SCD was defined as sudden cardiac arrest (SCA) or an appropriate ICD intervention. All parameters from HCM SCD-Risk Calculator have been obtained and the risk of SCD has been calculated for all patients during the first echocardiographic evaluation. ML model with variables from HCM SCD-Risk Calculator has been created. Both methods have been compared. RESULTS 20 patients reached an SCD end-point. 1 patient died due to SCA and 19 had an appropriate ICD intervention. Among them, there were respectively 6, 7 and 7 patients in the low, intermediate and high-risk group of SCD. 1 patient, who died, had a low risk. The ML model correctly assessed the SCD event only in 1 patient. According to ML, the risk of SCD ≤2.07% was a negative predictor. CONCLUSIONS The study did not show an advantage of ML over HCM SCD-Risk Calculator. Because of the characteristic of the dataset (approximately the same number of features and observations), the selection of machine learning algorithms was limited. Best results (evaluated using LOOCV) were achieved with a decision tree. We expect that bigger dataset would allow improving model performance because of strong regularization need in the current setup.


Author(s):  
Krishna Patel ◽  
Bo Hu ◽  
Michael Rothberg

Background/Aim: The 2013 ACC/AHA cholesterol management guidelines advise checking lipids in all adults aged > 20 years and repeating it every 4-6 years to identify individuals at high risk for atherosclerotic cardiovascular disease (ASCVD) because they may benefit from treatment. Statins can be considered in young adults with elevated ten year risk (defined as >5%) or LDL cholesterol >190 mg/dl. We aimed to assess the yield of lipid screening in this population. Methods: We conducted a retrospective cross-sectional study of patients aged 30-49 years who had lipid screening at their first primary care visit at a large health system from 2003-2012. Patients with known ASCVD and diabetes were excluded. We calculated 10-yr ASCVD risk by extrapolating the 2013 ACC/AHA ASCVD risk calculator to this population. Patients were subdivided by age in 5 year intervals, gender and history of smoking and hypertension. We calculated the percentage of patients with risk >5% and patients or LDL >190 mg/dl in each subgroup. Results: A total of 47,495 patients were included. The total number in each subgroup and the percentage with 10-yr estimated ASCVD risk >5% are shown in Table 1. Approximately half (49.2%, 23,388/47,495) the population had very low risk with only 18/ 23,388 (0.08%) non-smoking, non-hypertensive patients having an elevated risk. Only 1/15,618 (0.006%) non-smoking non-hypertensive females <50 years had a high risk. Less than 0.5% of non-smoking non-hypertensive males <45 years had a risk >5%. From 1% to >75% of population in other subgroups had an elevated risk depending on risk factors. Only 667/ 47,495 (1.4%) patients had LDL cholesterol >190 mg/dl. Conclusion: Yield of lipid screening is very low in non-smokers, especially in normotensive females <50 years and males <45 years, which constitute one-half of the screened population. Also, only 1.4% of the entire population cohort <50 years had elevated LDL>190 mg/dl. Guidelines for lipid screening should be reassessed for healthy non-smoking normotensive adults under 50 years of age.


Sexual Health ◽  
2018 ◽  
Vol 15 (3) ◽  
pp. 261 ◽  
Author(s):  
Lao-Tzu Allan-Blitz ◽  
Kelika A. Konda ◽  
Silver K. Vargas ◽  
Xiaoyan Wang ◽  
Eddy R. Segura ◽  
...  

Background Syphilis incidence worldwide has rebounded since 2000, particularly among men who have sex with men (MSM). A predictive model for syphilis infection may inform prevention counselling and use of chemoprophylaxis. Methods: Data from a longitudinal cohort study of MSM and transgender women meeting high-risk criteria for syphilis who were followed quarterly for 2 years were analysed. Incidence was defined as a four-fold increase in rapid plasma reagin (RPR) titres or new RPR reactivity if two prior titres were non-reactive. Generalised estimating equations were used to calculate rate ratios (RR) and develop a predictive model for 70% of the dataset, which was then validated in the remaining 30%. An online risk calculator for the prediction of future syphilis was also developed. Results: Among 361 participants, 22.0% were transgender women and 34.6% were HIV-infected at baseline. Syphilis incidence was 19.9 cases per 100-person years (95% confidence interval (CI) 16.3–24.3). HIV infection (RR 2.22; 95% CI 1.54–3.21) and history of syphilis infection (RR 2.23; 95% 1.62–3.64) were significantly associated with incident infection. The final predictive model for syphilis incidence in the next 3 months included HIV infection, history of syphilis, number of male sex partners and sex role for anal sex in the past 3 months, and had an area under the curve of 69%. The online syphilis risk calculator based on those results is available at: www.syphrisk.net. Conclusions: Using data from a longitudinal cohort study among a population at high risk for syphilis infection in Peru, we developed a predictive model and online risk calculator for future syphilis infection. The predictive model for future syphilis developed in this study has a moderate predictive accuracy and may serve as the foundation for future studies.


2020 ◽  
Vol 226 ◽  
pp. 70-73 ◽  
Author(s):  
Lawrence S. Kegeles ◽  
Adam Ciarleglio ◽  
Pablo León-Ortiz ◽  
Francisco Reyes-Madrigal ◽  
Jeffrey A. Lieberman ◽  
...  

2010 ◽  
Vol 105 (3) ◽  
pp. 334-337 ◽  
Author(s):  
David J. Kaplan ◽  
Stephen A. Boorjian ◽  
Karen Ruth ◽  
Brian L. Egleston ◽  
David Y. T. Chen ◽  
...  

2021 ◽  
pp. 1-10
Author(s):  
TianHong Zhang ◽  
LiHua Xu ◽  
HuiJun Li ◽  
HuiRu Cui ◽  
YingYing Tang ◽  
...  

Abstract Background Antipsychotics are widely used for treating patients with psychosis, and target threshold psychotic symptoms. Individuals at clinical high risk (CHR) for psychosis are characterized by subthreshold psychotic symptoms. It is currently unclear who might benefit from antipsychotic treatment. Our objective was to apply a risk calculator (RC) to identify people that would benefit from antipsychotics. Methods Drawing on 400 CHR individuals recruited between 2011 and 2016, 208 individuals who received antipsychotic treatment were included. Clinical and cognitive variables were entered into an individualized RC for psychosis; personal risk was estimated and 4 risk components (negative symptoms-RC-NS, general function-RC-GF, cognitive performance-RC-CP, and positive symptoms-RC-PS) were constructed. The sample was further stratified according to the risk level. Higher risk was defined based on the estimated risk score (20% or higher). Results In total, 208 CHR individuals received daily antipsychotic treatment of an olanzapine-equivalent dose of 8.7 mg with a mean administration duration of 58.4 weeks. Of these, 39 (18.8%) developed psychosis within 2 years. A new index of factors ratio (FR), which was derived from the ratio of RC-PS plus RC-GF to RC-NS plus RC-CP, was generated. In the higher-risk group, as FR increased, the conversion rate decreased. A small group (15%) of CHR individuals at higher-risk and an FR >1 benefitted from the antipsychotic treatment. Conclusions Through applying a personal risk assessment, the administration of antipsychotics should be limited to CHR individuals with predominantly positive symptoms and related function decline. A strict antipsychotic prescription strategy should be introduced to reduce inappropriate use.


2021 ◽  
pp. 1-8
Author(s):  
Gregory P. Strauss ◽  
Lisa A. Bartolomeo ◽  
Lauren Luther

Abstract Background Schizophrenia (SZ) is typically preceded by a prodromal (i.e. pre-illness) period characterized by attenuated positive symptoms and declining functional outcome. Negative symptoms are prominent among individuals at clinical high-risk (CHR) for psychosis (i.e. those with prodromal syndromes) and predictive of conversion to illness. Mechanisms underlying negative symptoms are unclear in the CHR population. Methods The current study evaluated whether CHR participants demonstrated deficits in the willingness to expend effort for rewards and whether these impairments are associated with negative symptoms and greater risk for conversion. Participants included 44 CHR participants and 32 healthy controls (CN) who completed the Effort Expenditure for Reward Task (EEfRT). Results Compared to CN, CHR participants displayed reduced likelihood of exerting high effort for high probability and magnitude rewards. Among CHR participants, reduced effort expenditure was associated with greater negative symptom severity and greater probability of conversion to a psychotic disorder on a cross-sectional risk calculator. Conclusions Findings suggest that effort-cost computation is a marker of illness liability and a transphasic mechanism underlying negative symptoms in the SZ spectrum.


Sign in / Sign up

Export Citation Format

Share Document